PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nedKargerHomeAlertsResources
 
Neuroepidemiology. Aug 2010; 35(2): 117–122.
Published online Jun 15, 2010. doi:  10.1159/000313443
PMCID: PMC2945265
White Matter Hyperintensity and Cognitive Functioning in the Racial and Ethnic Minority Cohort of the Framingham Heart Study
Karina Stavitsky,a Yangchun Du,b Daniel Seichepine,a Thomas M. Laudate,a Alexa Beiser,bcd Sudha Seshadri,cd Charles DeCarli,e Philip A. Wolf,cd and Rhoda Aucd*
aDepartment of Psychology, Boston University, Boston, Mass., USA
bDepartment of Biostatistics, Boston University School of Public Health, Boston, Mass., USA
cDepartment of Neurology, Boston University School of Medicine, Boston, Mass., USA
dFramingham Heart Study, Framingham, Mass., USA
eDepartment of Neurology and Center for Neuroscience, University of California, Davis, Sacramento, Calif., USA
*Rhoda Au, PhD, Department of Neurology, Boston University School of Medicine, 72 E. Concord Street, B608, Boston, MA 02118 (USA), Tel. +1 617 638 5450, Fax +1 617 638 8086, E-Mail rhodaau/at/bu.edu
Received September 25, 2009; Accepted April 8, 2010.
Background
Previous studies have demonstrated an association between white matter hyperintensities (WMH) and cognitive performance primarily in Caucasian samples, limiting generalizability to other ethnic and racial groups. This study investigated the association of WMH and cognition in an ethnic and racial minority cohort (Omni) of the Framingham Heart Study and compared these results to the Caucasian (Offspring) cohort.
Methods
Quantitative brain MRI and neuropsychological evaluations were performed on stroke- and dementia-free participants. Cognitive assessment included verbal memory, visuospatial memory and organization, language, and executive functioning. Linear regression models were conducted to assess the association between WMH and cognitive function.
Results
The Omni group presented with demographic factors that significantly differed from those of the Offspring group: they were younger, but had more stroke risk factors such as hypertension. In the Offspring group, WMH volume was significantly associated with poorer performance on tests of executive function and visual organization. No significant associations between WMH and cognitive measures were found in the Omni group, but no differences (significant interaction terms) were seen between the regression coefficients.
Conclusions
The Omni cohort had greater variability in factors that may mediate the association of WMH and cognition. More research is needed to investigate how stroke risk factors impact on the occurrence of WMH and its association with cognition in more diverse cohorts.
Key Words: White matter hyperintensities, Cognition, Executive function, Framingham Heart Study, Magnetic resonance imaging, Cultural/ethnic diversity
Vascular factors resulting in cerebrovascular disease are related to cognitive decline in individuals without neurodegenerative disease. In particular, multiple studies have found associations between stroke risk factors and impairments in memory [1, 2] and executive functions [1,2,3,4,5]. Some studies have additionally demonstrated that stroke risk factors such as high blood pressure and diabetes can lead to general cognitive impairment [2, 6] and dementia [7, 8]. The specific causes of cognitive impairment resulting from cerebrovascular disease are unknown, but one potential marker of the resulting neuropsychological impairment is damage to subcortical white matter tracks seen on MRI in clinically asymptomatic individuals as white matter hyperintensities (WMH).
WMH are associated with decrements in cognitive functions associated with the frontal lobes including psychomotor speed, attention, and organization as well as with memory functions [9,10,11,12,13,14,15,16]. One study that examined regional white matter and cognitive performance over the adult lifespan demonstrated that frontal white matter was associated with tasks of memory and executive functioning, and that the relation between age and neuropsychological performance may be mediated by frontal lobe white matter [17].
Few studies, however, have examined the association of white matter changes and cognitive impairment in ethnic minority cohorts, despite evidence that some groups may present with greater vascular risk factors implicating the possibility of more severe vascular pathology and resulting cognitive impairment in those groups [18]. One recent study based on an ethnic minority cohort did examine WMH and cognition and found that WMH volume significantly predicted performance on tasks of psychomotor functioning and cognitive flexibility [19]. This study included individuals from Caucasian, Hispanic and African American ethnicities. However, the study only examined the association of WMH to executive functioning and not to other neuropsychological domains such as memory and visuospatial functioning. In addition, the ethnic minority groups were combined in all analyses despite the differential stroke risk factors that have been found in African American, Hispanic, and Caucasian individuals [20]. Another study that examined WMH in African-Caribbean individuals in comparison to Caucasians found that the African-Caribbean participants exhibited greater parieto-occipital white matter lesion volumes and also displayed poorer performance on tests of executive function [21]. This study was also limited by using a single ethnic minority cohort and only examining performance on a task of executive function despite evidence of a more widespread influence of WMH on cognition.
The current study examines an extension of the original Framingham Heart Study Offspring cohort, which was predominantly Caucasian and reflected the population of Framingham, Mass., USA, at the time of the enrollment of the original Framingham study cohort. In the last decade, there has been an effort to recruit ethnically diverse participants in order to examine the generalizability of the reports that were based on the predominantly Caucasian cohort. Therefore, the aim of this study is to determine whether previously reported associations between brain volume, WMH, and neuropsychological test performance apply to the ethnic minority cohort of the Framingham Heart Study.
Study Participants
The Framingham Study Offspring cohort was enrolled in 1971 and has had 7 follow-up evaluations over a 30-year period. The current study encompasses neuropsychological testing and brain MRI which took place from 1999 to 2004 on a subset of the surviving members of the Offspring cohort. Of the 2,187 Offspring participants who agreed to partake in the neuropsychological testing and brain imaging, 2,161 were included in the current analyses. The remaining 26 participants were excluded based on consensus review process which determined the presence of clinical stroke [22], probable dementia [23], or other neurologic conditions [20]. The Offspring group was significantly younger than the Omni group, so for the current study, we only include subjects who are 655 years old, bringing the sample size to 1,582 Offspring participants.
Since the inception of the Framingham Heart Study, the racial and ethnic composition of Framingham and the surrounding towns has changed. For example, by 1990, 10% of the Framingham population was Hispanic and the numbers of non-Hispanic African Americans and Asians was also increasing. Hence, the Heart Study undertook recruitment of minority residents of the Metro west area to reflect the diversity of the Framingham community and to help identify whether findings from one population subgroup generalize to other subgroups. In 1994, the Framingham Heart Study began recruitment of men and women between the ages of 40 and 74, consisting of Hispanic, non-Hispanic black, Asian, and Native-American residents of Framingham and 24 surrounding towns.
For as many as 24% of adult Hispanic residents of Framingham, English was not the primary language, therefore, recruitment, clinical evaluation and neuropsychological testing of these subjects was facilitated by bilingual/bicultural examiners. The current study did not include participants for whom the neuropsychological testing was not done in English, as the aim of this study is to relate the previously reported findings of the Offspring cohort to those of the Omni cohort and validity testing has yet to be done on this subset data. Since the current study involved cohort comparison analysis of factors that are closely related to age, only participants of age 55 and older were included in the study in order to minimize age differences between the groups. 113 ethnic minority participants had MRI data and met the inclusion criteria for this study, of which 48.7% were African American, 21.2% were Hispanic, 28.3% were Asian/Pacific Islander and 1.8% were others. The exclusion criteria applied were the same as those for the Offspring cohort, excluding 7 participants for stroke, dementia, and other neurological conditions. The institutional review board at Boston University School of Medicine, Boston, Mass., USA, approved the study protocol and all participants provided informed consent.
MRI Measures
The methods for MRI acquisition, brain volume assessment [24] and WMH volume quantification [25] have been previously described. The same MRI methods were used for the Offspring and Omni participants. WMH volume was divided by the total cranial volume (TCV) (and multiplied by 100) and log-transformed. The log-transformed WMH volume (LWMHIV) was considered as a continuous variable in the current analysis.
Neuropsychological Test Battery
The neuropsychological assessment was a comprehensive battery including tests of verbal learning and memory (Wechsler Memory Scale-III Logical Memory and Paired Associates), visual memory (Wechsler Memory Scale-III Visual Reproduction), abstract reasoning (Wechsler Adult Intelligence Scale-III Similarities), visuospatial organization (Hooper VOT), language (Boston Naming Test) and executive functioning (Trails A and B).
Statistical Analysis
χ2 tests for categorical variables and t tests for continuous variables were used to compare the demographic and clinical characteristics between Offspring and Omni, and to compare the three racial subgroups within the Omni population. Natural log transformations were used to normalize the skewed distributions of Trails A and B, Trail B minus Trail A, Boston Naming, and Hooper VOT. The neuropsychological scores used in the analyses are standardized residuals from sex-specific regression analyses adjusting for age and education. To assess the relationship between individual cognitive measures and WMH, linear regression analyses were performed separately for the Offspring and Omni groups. Regression coefficients were reported for each individual cognitive measure score, representing the change in the score for one unit of change of LWMHIV. To examine whether the regression coefficients of WMH between the Omni and Offspring groups are significantly different, we used an omnibus model where cognitive performance served as the outcome, with WMH volume as the predictor variable, a group indicator variable (Omni is the reference group), and an interaction term (group × WMH volume).
The demographic and clinical variables for this subset of participants can be found in table table1.1. The Omni participants were significantly younger, had larger total cerebral brain volume (TCBV), had smaller WMH/TCV ratio, had significantly less WMH, and were more likely to have hypertension but less likely to be smokers than the Offspring participants. Table Table22 shows the demographic and clinical characteristics for African American, Hispanic and Asian/Pacific Islander participants within the Omni cohort. The three groups were significantly different in age, with the African American and Pacific Islander/Asian groups being older than the Hispanic group. In addition, the Hispanic group had the largest TCBV, followed by the African American and then the Pacific Islander/Asian group.
Table 1
Table 1
Characteristics comparison between Offspring and Omni ≥55 years of age
Table 2
Table 2
Characteristics of study sample in the first Omni examination
As expected, in the Offspring group, WMH was significantly associated with a test of executive functioning (Trail B – Trail A; β = 0.07, p < 0.01), indicating that higher WMH volume is associated with longer time to complete the task. WMH was also associated with a test of visual organization (Hooper VOT; β = −0.06, p < 0.01), indicating that greater WMH is related to poorer performance on this measure (table (table3).3). In the Omni group, no significant associations between WMH and cognitive testing were found. There were no significant interactions between the Omni and Offspring groups in regard to the relation between WMH and cognition, indicating similar effects for both groups, although this may be due to low power in our sample.
Table 3
Table 3
Associations between neuropsychological variables and LWMHIV in Offspring and Omni participants separately
Given the significant group differences in some stroke risk factors including smoking and hypertension, the analyses were repeated controlling for stroke risk factors. When controlling for smoking, diabetes and hypertension, there were no changes to the above findings. Although the regression coefficients and p values did change slightly, the conclusions of the regression analyses remain the same. Significant associations between WMH and Trail A–B and Hooper VOT remained in the Offspring group while no significant associations between WMH and cognition were found in the Omni participants. Finally, no significant interaction terms were found, again demonstrating that the effects in the two groups are similar.
The findings from the present study are among the few contributions to the literature on the relation between WMH and cognitive functioning in ethnically and racially diverse populations. These findings extend previous reports, which primarily used Caucasian samples, to a diverse group of individuals living within the United States. Following up on Au et al. [9], we found that in an age-comparable (55 years and older) subset of the Offspring cohort, higher WMH is a predictor of performance on tests of executive function and visuospatial organization; no such associations were seen in the ethnically diverse cohort. The majority of the effect sizes for each of the cognitive measures were similar in the Offspring and Omni groups, indicating that no differences were found in the impact of WMH on cognitive performance. Only a test of visuospatial organization showed some indication of WMH having a different or opposite effect on the Omni in comparison to the Offspring cohort, where greater WMH predicted lower performance on the task in the Offspring but not the Omni group.
In this sample of racially and ethnically diverse individuals, the cumulative effect of various stroke risk factors may impact the association of WMH and cognition in a way that is different than is seen in a Caucasian sample. Most research in Caucasians has shown that the combination of factors of older age, hypertension, and smoking can lead to greater risk of stroke, WMH, and cognitive impairment [26]. In the current study, the Omni cohort was significantly younger, had lower occurrence of large WMH, and had a greater proportion of individuals with hypertension but fewer smokers compared to the Offspring cohort. While their younger age is typically associated with less WMH and better cognitive performance, the Omni cohort had higher rates of hypertension, which has been associated with decrements in cognitive performance in other studies. Having a greater proportion of individuals with hypertension may put the Omni group at greater risk for both WMH and subsequent cognitive decrements at a later age, which longitudinal follow-up will determine. Alternatively, a higher rate of smoking in the Offspring cohort, though not associated with lower cognitive performance per se, is a significant stroke risk factor and may impact cognitive performance and WMH by its effects on the cardiovascular system. Although our follow-up covariate analysis examining the impact of these stroke risk factors did not change the results significantly, with the small sample size of our Omni group, significant impact of the stroke risk factors on our findings may have been obscured. Thus the differential impact of these risk factors on the associations between WMH and cognition in Caucasian and ethnic minorities should be explored further in future studies.
There are limitations to this study that may account for why we did not see an association between WMH and neuropsychological variables such as executive functioning and memory consistent with previous reports. The Omni group in the current study had a smaller sample size than the Offspring group, resulting in a decrease of power to detect potentially significant associations. In addition, the power in our analyses was reduced by using WMH as a continuous variable, not as a binary variable as was done in our previous report [9]. This may account for differences seen between the outcomes in the current Offspring sample in comparison to those reported by Au et al. [9]. Limited sample size also prevented us from examining the impact of WMH on cognition in each of the ethnic groups individually.
The Omni cohort is not only ethnically diverse, but also contains variability in the different factors that may mediate the association of WMH and cognition. In this regard, more research is needed to investigate how hypertension and other stroke risk factors impact on both the occurrence of WMH and its association with cognition in more ethnically diverse cohorts. These findings will be important in order to further elucidate whether there are differences in these associations between Caucasians and other cohorts.
Acknowledgements
Supported by the Framingham Heart Study's National Heart, Lung, and Blood Institute contract (N01-HC-25195) and by grants (#AG16495 and #AG08122) from the National Institute on Aging and grant (#NS17950) from the National Institute of Neurological Disorders and Stroke.
1. Cerhan JR, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG, Hays MA, Crum LD, Heiss G. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology. 1998;44:95–105. [PubMed]
2. Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004;35:404–409. [PubMed]
3. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58:643–647. [PubMed]
4. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42–48. [PubMed]
5. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke. 1998;29:2334–2340. [PubMed]
6. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29:494–511. [PubMed]
7. Pasquier F, Boulogne A, Leys D, Fontaine P. Diabetes mellitus and dementia. Diabetes Metab. 2006;32:403–414. [PubMed]
8. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004;63:1882–1891. [PubMed]
9. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, D'Agostino RB, DeCarli C. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006;63:246–250. [PubMed]
10. Bigler ED, Lowry CM, Kerr B, Tate DF, Hessel CD, Earl HD, Miller MJ, Rice SA, Smith KH, Tschanz JT, Welsh-Bohmer K, Plassman B, Victoroff J. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. Neuropsychology. 2003;17:339–352. [PubMed]
11. Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, Kalaria R, Firbank M, Wesnes K, Ballard C. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke. 2004;35:1270–1275. [PubMed]
12. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology. 2001;56:1539–1545. [PubMed]
13. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke. 1999;30:1548–1553. [PubMed]
14. Gunning-Dixon FM, Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia. 2003;41:1929–1941. [PubMed]
15. O'Brien JT, Wiseman R, Burton EJ, Barber B, Wesnes K, Saxby B, Ford GA. Cognitive associations of subcortical white matter lesions in older people. Ann NY Acad Sci. 2002;977:436–444. [PubMed]
16. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63:246–253. [PMC free article] [PubMed]
17. Brickman AM, Zimmerman ME, Paul RH, Grieve SM, Tate DF, Cohen RA, Williams LM, Clark CR, Gordon E. Regional white matter and neuropsychological functioning across the adult lifespan. Biol Psychiatry. 2006;60:444–453. [PubMed]
18. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233–1241. [PubMed]
19. Wright CB, Festa JR, Paik MC, Schmiedigen A, Brown TR, Yoshita M, DeCarli C, Sacco R, Stern Y. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke. 2008;39:800–805. [PMC free article] [PubMed]
20. Brickman AM, Schupf N, Manly JJ, Luchsinger JA, Andrews H, Tang MX, Reitz C, Small SA, Mayeux R, DeCarli C, Brown TR. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol. 2008;65:1053–1061. [PMC free article] [PubMed]
21. Birns J, Morris R, Jarosz J, Markus H, Kalra L. Ethnic differences in the cerebrovascular impact of hypertension. Cerebrovasc Dis. 2008;25:408–416. [PubMed]
22. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham study. Stroke. 1982;13:290–295. [PubMed]
23. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology. 1992;42:115–119. [PubMed]
24. Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, D'Agostino RB, DeCarli C. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology. 2004;63:1591–1599. [PubMed]
25. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D'Agostino R, Wolf PA. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging. 2005;26:491–510. [PubMed]
26. Williams LR, Hutchinson CE, Jackson A, Horan MA, Jones M, McInnes L, Rabbitt PM, Pendleton N. Clinical correlates of cerebral white matter hyperintensities in cognitively normal older adults. Arch Gerontol Geriatr. 2010;50:127–131. [PubMed]
Articles from Neuroepidemiology are provided here courtesy of
Karger Publishers